Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03894215
Title Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Agenus Inc.
Indications

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

cervical adenocarcinoma

Therapies

Balstilimab

Balstilimab + Zalifrelimab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.